USA - New York Stock Exchange - NYSE:PHIN - US71880K1016 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to PHIN. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-29 | UBS | Maintains | Neutral -> Neutral |
| 2025-10-06 | UBS | Maintains | Neutral -> Neutral |
| 2025-09-10 | B of A Securities | Maintains | Buy -> Buy |
| 2025-08-12 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-25 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-14 | UBS | Maintains | Neutral -> Neutral |
| 2025-05-19 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-15 | B of A Securities | Maintains | Buy -> Buy |
| 2025-04-10 | UBS | Downgrade | Buy -> Neutral |
| 2025-04-10 | B of A Securities | Initiate | Buy |
| 2025-03-24 | CL King | Initiate | Buy |
| 2025-01-30 | Northland Capital Markets | Initiate | Outperform |
| 2025-01-16 | UBS | Maintains | Buy -> Buy |
| 2024-09-25 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2024-09-04 | UBS | Initiate | Buy |
| 2024-03-12 | Morgan Stanley | Initiate | Overweight |
| 2024-03-11 | Morgan Stanley | Initiate | Overweight |
| 2023-09-05 | Exane BNP Paribas | Initiate | Outperform |
11 analysts have analysed PHIN and the average price target is 63.58 USD. This implies a price increase of 3.13% is expected in the next year compared to the current price of 61.65.
The consensus rating for PHINIA INC (PHIN) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering PHINIA INC (PHIN) is 11.